INDUSTRY CITY AND SUNSET PARK — Brooklyn-based biotechnology company Cresilon Inc. uncovered a hemostatic gel technology that will make traumatic brain injuries (TBI) significantly less devastating.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback